Every researcher knows the hopeless silence that accompanies a weak progress report. This was recently our situation. We needed novel compounds. Specifically, we required synthetic, non-natural nucleoside triphosphates. Our own attempts to synthesize, purify and analyze the compounds were proceeding too slowly and threatening our grant. Commercially available compounds were not an option because they were either outrageously priced or structurally too different from what we needed.
Out of desperation, I reached out to some nucleotide suppliers to see if they could, at least, point us in the right direction. After many discouraging responses, we hit gold. Steven of ChemCyte was sympathetic and, like a skilled surgeon, set to work to help solve our problem. We quickly devised a way that they could provide our desired substrates at a good price. These were complex, novel compound and, inevitably, their synthesis required optimization. We were not charged extra by ChemCyte for their time or resources to improve the yields. Most excitingly, we received the precious compounds on time!
ChemCyte’s product quality, due diligence, and turn-around-time was outstanding. With these compounds, we performed our key experiments. As a result, during our formal research update, we enjoyed the encouraging chatter and congratulations that accompanies accomplished grant milestones.
J. R., PhD Organic Chemistry and Synthetic Biology Harvard University July 9, 2018